AVITA Medical (RCEL) Interest Coverage Ratio Growth (1y) (2019 - 2026)
AVITA Medical (RCEL) Interest Coverage Ratio Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -71.56% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 68.09% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 28.95% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 34.84% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 12.01% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -29.36% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 16.91% |
| 10 | AVITA Medical | 309.50 Mn | 298.36 Mn | 17.77 Mn | 47.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.38% |
| Dec 31, 2025 | -8.54% |
| Sep 30, 2025 | 28.94% |
| Jun 30, 2025 | 23.23% |
| Mar 31, 2025 | 24.41% |
| Dec 31, 2024 | 29.87% |
| Sep 30, 2024 | -250.97% |
| Jun 30, 2024 | 60.83% |
| Mar 31, 2024 | 51.73% |
| Dec 31, 2023 | -164.31% |
| Sep 30, 2023 | 41.18% |
| Mar 31, 2023 | -333.95% |
| Sep 30, 2022 | 42.05% |
| Mar 31, 2022 | 80.69% |
| Sep 30, 2021 | 85.62% |
| Jun 30, 2021 | -8,884.32% |
| Mar 31, 2021 | 98.98% |
| Dec 31, 2020 | 99.99% |
| Sep 30, 2020 | -167.93% |
| Jun 30, 2020 | 99.95% |